Alpha Crest Capital Management LLC Gilead Sciences, Inc. Transaction History

Alpha Crest Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $6.93 Million - $8.88 Million	-110,669 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$61.62 - $67.78 $3.72 Million - $4.1 Million	-60,432 Reduced 35.32%	110,669 $7.19 Million
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $7.07 Million - $7.81 Million	113,178 Added 195.39%	171,101 $10.8 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $1.1 Million - $1.24 Million	17,826 Added 44.46%	57,923 $3.91 Million
Q1 2019 May 10, 2019	BUY	$62.53 - $70.05 $641,870 - $719,063	10,265 Added 34.41%	40,097 $2.61 Million
Q4 2018 Feb 11, 2019	BUY	$60.54 - $79.0 $1.81 Million - $2.36 Million	29,832 New	29,832 $1.87 Million

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.